Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Predicting kidney stone recurrence and complications using precision medicine

Official title: Prediction of Recurrence and Complications of Nephrolithiasis Using a Precision Medicine Approach

Run by Centre Hospitalier Universitaire, Amiens · NCT05237063 · Data updated 2026-11-12

This study is trying to find out what causes kidney stones to come back so that we can help people avoid getting them again.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment2000 (estimated)
SponsorCentre Hospitalier Universitaire, Amiens
Academic / other
Locations1 site (Amiens)
StatusRecruiting
StartedJanuary 13, 2021
Main results expectedFebruary 2026
Study endsFebruary 2031
Registry record updatedFebruary 8, 2023
Trial IDNCT05237063 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18 and older who have experienced at least one renal colic attack.

Probably not a fit

Patients who are pregnant, breastfeeding, or unable to provide informed consent may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to identify the clinical, biological, genetic, molecular, and environmental factors that predict the recurrence of kidney stones, a common condition affecting a significant portion of the population. Participants will provide blood and urine samples during routine follow-up visits over a period of five years. The samples will be analyzed to uncover determinants that could help in managing and preventing future episodes of nephrolithiasis. The study is designed to enhance understanding of kidney stone formation and recurrence.

Why it matters

Potential benefit: If successful, this study could lead to personalized prevention strategies for patients at risk of recurrent kidney stones.

How similar studies have gone: While there have been studies on kidney stones, this precision medicine approach focusing on a comprehensive set of predictive factors is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults (≥18 years old), male or female ,
* Persons able to understand and object to the information provided (at the discretion of the investigator)
* Patient affiliated to social security
* Patient agreeing to sign the informed consent form
* patient having presented at least one renal colic attack before inclusion

Exclusion Criteria:

* Pregnant or breastfeeding woman.
* Persons deprived of liberty,
* Adults under legal protection guardianship, or curators or unable to express their consent.
* Patient refusing to participate in the study
* Patient in an emergency situation

Where it's running

  • CHU Amiens Nord
    Amiens, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.